(2026). In Silico Discovery of 1,3,4‐Thiadiazole Derivatives as VEGFR‐2 Inhibitors for Breast Cancer Liver Metastasis via QSAR modeling, Molecular Docking, ADMET, and DFT Studies. Journal of Chemometrics.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"In Silico Discovery of 1,3,4‐Thiadiazole Derivatives as VEGFR‐2 Inhibitors for Breast Cancer Liver Metastasis via QSAR Modeling, Molecular Docking, ADMET, and DFT Studies."
Journal of Chemometrics 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"In Silico Discovery of 1,3,4‐Thiadiazole Derivatives as VEGFR‐2 Inhibitors for Breast Cancer Liver Metastasis via QSAR Modeling, Molecular Docking, ADMET, and DFT Studies."
Journal of Chemometrics, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.